Balancing Compliance with Economics: The New Role of Manufacturing

As process manufacturers search for ways to trim costs and boost revenue – whether that be by increasing yield or speeding time to value – they can view the FDA’s inspections and PAT recommendations as opportunities to better understand manufacturing processes across the organization. Today’s IT tools enable data intensive decision-making that places manufacturing at the center of new initiatives that drive a synergistic balance between compliance and the bottom line.

About the Author

Aegis Analytical Corp.

Aegis Analytical Corp.

Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates